Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Total Liabilities (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Total Liabilities for 9 consecutive years, with $3.9 billion as the latest value for Q1 2026.

  • For Q1 2026, Total Liabilities rose 7.84% year-over-year to $3.9 billion; the TTM value through Mar 2026 reached $3.9 billion, up 7.84%, while the annual FY2025 figure was $3.8 billion, 5.68% up from the prior year.
  • Total Liabilities hit $3.9 billion in Q1 2026 for Select Medical Holdings, up from $3.8 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $6.3 billion in Q4 2022 and bottomed at $3.6 billion in Q4 2024.
  • Average Total Liabilities over 5 years is $5.3 billion, with a median of $6.1 billion recorded in 2022.
  • Year-over-year, Total Liabilities tumbled 41.06% in 2025 and then grew 7.84% in 2026.
  • Select Medical Holdings' Total Liabilities stood at $6.3 billion in 2022, then decreased by 2.54% to $6.1 billion in 2023, then plummeted by 40.96% to $3.6 billion in 2024, then rose by 5.68% to $3.8 billion in 2025, then rose by 3.15% to $3.9 billion in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $3.9 billion, $3.8 billion, and $3.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.